This article reviews those challenges and presents a solution based on a multiplexed channel architecture that delivers ultra-high resolution, along with very low-power consumption and silicon area.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Membrane proteins are key targets for therapeutic intervention using antibody biologics. Over 60% of FDA-approved drugs act on these proteins. Studying them is challenging because the proteins ...

Montage Technology's Gen1 MRCD and MDB chipset, supporting speed up to 8800 MT/s, has already secured volume purchases from major memory manufacturers. The new Gen2 engineering samples push ...